Liège, Belgium, - November 5, 2010. Eurogentec S.A. announced today that Mr. Marc Molina will take over as Global IVD Business Development Director, responsible for growing Eurogentec’s GMP contract manufacturing business in the diagnostic markets. He succeeds Peter Haima, who has been heading the global IVD services department since 2006. Haima decided to make a career move and focus all his attention on his own coaching and consulting activities for IVD and Biotech professionals.
Marc Molina joins Eurogentec from Stago corporation, where he was Business Development Executive. His diverse background in IVD includes business development and international sales, with responsibility for managing teams, budgets and strategy. With global responsibility for Eurogentec’s IVD CMO business, Marc Molina will be based at Eurogentec’s headquarters in Liege, Belgium, and will manage the company’s IVD sales, support and distribution teams based in the US and Europe.
Jean-Pierre Delwart, CEO of Eurogentec, recognized the former IVD director and his valuable contributions to the Eurogentec company: “In the past 4 years, Peter Haima has played a key role in developing our global diagnostic contract manufacturing business. Thanks to his vision, commitment and hard work, he has succeeded in strengthening the position and positive image of Eurogentec in the IVD and molecular diagnostic fields. As an experienced IVD marketing and sales professional, Marc Molina takes his place as our company’s Global IVD Business Development Director.’’
ABout EurogEntEc
Eurogentec S.A. is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. The Company provides a wide range of expertise in small- and large scale DNA and RNA manufacturing. Together with its subsidiary AnaSpec (Fremont, California), Eurogentec is also a leading provider of integrated proteomics solutions for life science research and diagnostics with expertise in peptides synthesis, labeled peptides, antibodies,fluorescent dyes and enzyme activity assays.
The Company is operating full-service, state-of-the-art GMP- manufacturing facilities in Belgium that provide high-value custom biologics (including PCR enzymes) and a wide range of oligonucleotide-based components for diagnostic and therapeutic applications. Eurogentec’s GMP/QSR compliant and ISO 13485:2003 certified clean room oligonucleotide manufacturing facility in Europe is complemented by additional GMP production facilities in Asia and North America.
Headquartered in Liège, Belgium, Eurogentec is part of Kaneka Corporation group of Companies, and has subsidiaries in France, Germany, the UK, the Netherlands, Switzerland and North America with additional manufacturing facilities in the United States, Japan and Singapore. The Company employs 375 people globally. Please visit www.eurogentec.com for more information.
contacts
GLOBAL RESPONSIBILITy Mr. Marc Molina Global IVD Business Development Director Eurogentec S.A. Rue Bois Saint-Jean 5 4102 Seraing, Belgium Tel: +32 (4) 372 74 00 Fax: +32 (4) 372 75 00 E-mail: m.molina@eurogentec.com
NORTH AMERICA Mr. Harrison Ransom IVD Business Development Manager Eurogentec North America, Inc. 11111 Fl intkote Avenue San Diego, CA 92121-1222 Tel: +1(415) 681-4927 Fax: +1(415) 680-1686 E-mail: h.ransom@eurogentec.com
